Cochlear Implant Unilateral denied as experimental or investigational by UnitedHealthcare?

UnitedHealthcare's specific coverage criteria for cochlear implant unilateral are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why UnitedHealthcare Denies Unilateral Cochlear Implants as Experimental

UnitedHealthcare's "experimental or investigational" denial indicates that the plan's medical policy — at the time of the review — either classified cochlear implantation for the patient's specific clinical profile as not yet meeting the plan's evidence standard, or that the specific device or surgical technique was categorized as investigational. This denial is uncommon for standard unilateral cochlear implantation in classic candidates, but it can arise for patients whose hearing loss profile, age, or anatomy falls outside the population most prominently featured in the plan's evidence review, or when a newer device model is submitted.

This type of denial is legally and clinically significant. It carries a high bar for the plan to defend on appeal, because cochlear implantation has a long-established body of clinical evidence and broad professional society endorsement.

## Why This Denial Is Appealable

An experimental denial must be grounded in the plan's evidence-based medical policy. UHC is required to disclose that policy and identify which specific evidence standard the requested service failed to meet. When a service has broad professional society support and established clinical use, an experimental denial is among the most vulnerable to reversal on external review — because an independent physician reviewer will assess whether the denial reflects generally accepted medical practice.

## Your Federal Appeal Rights

• Internal appeal: Request UHC's complete clinical policy document for cochlear implants and the specific evidence criteria used in the denial. The appeal letter should address each criterion directly.
• External review (ACA §2719): This is particularly powerful for experimental denials. The external reviewer — an independent physician specialist, not affiliated with UHC — will assess whether the service is consistent with generally accepted medical practice. If it is, the denial must be overturned.
• Expedited external review: Available when health is at serious risk due to delay; decision required within 72 hours.
• ERISA §503: For employer-sponsored plans, you are entitled to all documents, clinical policies, and evidence used to classify the service as experimental.
• Timeline: Internal appeal: typically 180 days from denial notice. External review: generally within four months of the final internal denial.

## Documentation to Gather

• FDA clearance / approval records for the device: Confirm the device is FDA-cleared or approved for the specific indication and provide that documentation. An FDA-approved device used within its labeled indications cannot reasonably be called experimental.
• Professional society position statements: Reference (without citing statistics) the relevant otolaryngology and audiology professional societies' published positions on cochlear implantation for the patient's clinical profile. The American Academy of Otolaryngology–Head and Neck Surgery (AAO-HNS) and related bodies have established position guidance.
• Treating physician letter: A detailed letter from the implanting surgeon or ENT addressing the specific criteria in UHC's clinical policy and explaining why the requested service meets the accepted standard of care for this patient.
• Audiological candidacy evaluation: Complete audiological documentation demonstrating the patient's hearing profile and the clinical basis for cochlear implant candidacy.

## Criteria-Mapping Structure

Obtain UHC's Clinical Coverage Policy for cochlear implants (available on UHC's provider website or by request). Map each evidence criterion:

| UHC Evidence Criterion for "Established" Status | Evidence Addressing That Criterion | |---|---| | [Quote each criterion from the UHC policy verbatim] | [Cite FDA records, professional society guidance, or chart findings] |

The goal is to demonstrate that the requested service meets every element of the plan's own definition of established — not experimental — care.